Business Development Regional Sales

BRIAN J. NEPPL

**** ****** **. ********@*****.*** Naperville, IL 60564 cell 630-***-****

KEY ATTRIBUTES:

Oncology, Genomics, Precision Medicine, Business Development Solutions, Improving Workflows, Strategic Client Growth, Multi-President Club Award Winner, Leadership, Team-Player, Peer Development, Collaboration

EXPERIENCE:

SimBioSys, Inc (Consulting Agreement) February 2024 to August 2024

Regional Sales Director

Recent FDA clearance and Commercial Roll-Out of Software-based Precision Medicine platform TumorSight Viz converting 2D DCE MRI to interactive 3D representations. Provides Breast Surgeon additional resource and information for Surgical Planning and Clinical Decision Support. Future applications for Prone-to-Supine conversion, Neoadjuvant Response and Risk Assessment. Series B Funding denied resulting in RIF.

Uncovered 11 new opportunities within first 3 months providing rapid strength to pipeline

Creative strategy offered and implemented for Prone-to-Supine beta testing

Key interaction with Executive Levels providing resource for budget and contract negotiation

Agendia, Inc. February 2014 to August 2023

Regional Director – January 2018 to August 2023

Covering multi-state region leading 7 Molecular Oncology Specialists and assisting in territory analysis, account strategies, effective targeting, and clinical knowledge advancement to achieve targeted company growth volumes. Continuous inspection of strategies, account trending, plan achievement, and skill advancement. Developed Key Regional KOL initiatives to leverage base business into broader bandwidth adoption.

FY 2022 - #1 Region – 103% to plan; Regional Director of the Year – PRESIDENT’S CLUB

Developed and coached 2022 Rookie of the Year

FY 2021 – 21% YoY Growth

Developed and coached 2021 Rookie of the Year; promoted another MOS to region trainer

FY 2020 – 15% YoY Growth

Developed and coached 2020 Rookie of the Year

Senior Molecular Oncology Specialist – January 2017 to December 2017

FY 2017 – 24% YOY Growth, Century Club

Molecular Oncology Specialist – February 2014 to December 2016

MammaPrint + BluePrint Genomic Assays for early-stage breast cancer. Covering Chicago area, Southern IL, and NW IN, targeting Medical Oncologists, Breast Surgeons and Pathologists. Targeted account strategy based on multi-discipline dynamics and nuances. Successful year-to-year growth and new account adoption.

FY 2016 – 28% YOY Growth – PRESIDENT’S CLUB - ranked 2nd

Xoft, a subsidiary of iCAD February 2012 to January 2014

Midwest Regional Business Development Manager

Accelerate the adoption of 50kv electronic brachytherapy radiation treatment technology for Breast IORT, 5 day APBI, skin/surface, and endometrial applications utilizing Xoft’s Axxent System. Call points include Breast Surgeons, Surgical Oncologists, Radiation Oncologists, Physicists, Dermatologists, and C-Level.

Closed Rush Univ Med Center for IORT and Gyne applications, implementing as Center of Excellence

Extensive presentations to multi-discipline teams and C-Level reviewing clinical details and ROI analysis

Instigated IHN adoption process strategies, ie Wheaton Franciscan, McLaren, Aurora, Advocate, IU Health

Neurowave Medical Technologies, LLC November 2010 to January 2012

Senior Sales Manager

VC-backed start-up, call points are Surgeons, Anesthesiologists, PACU/Recovery to drive transdermal neuromodulation device (Reletex) for relief and control of post-op nausea, Medical Oncologists (Nometex) for relief and control of chemotherapy-induced nausea, and OB/GYN (PrimaBella) for relief of pregnancy-induced nausea.

Initiated 4 new Reletex accounts, generated largest revenue order to date – 1st of 8 regions

Signed 6 new Nometex accounts for trial/evaluation program – 1st of 5 regions

Closed 5 new accounts in September (4 PrimaBella, 1 Nometex), most in one month in company history

Calypso Medical June 2010 to August 2010

Regional Sales Manager

VC-backed start-up. Target key Urology/Radiation Oncology referral practices to adopt ‘GPS of the Body’, real-time tracking technology managing prostate motion during radiation treatment. C-Level ROI results.

Immediate interest turnaround implemented to free-standing center target with doctor/CLevel presentation.

Integrated ground-level support through physicist group to start budgeting process for acquisition.

Hologic (Cytyc Surgical Products) September 2005 to March 2010

District Sales Manager – April 2007 to March 2010

Managed surgical and biopsy specialists (8-11 direct reports). Key Breast Surgeon and Radiation Oncology thought leader contacts and strategies. Detailed approach in developing goals, coaching, training, and measuring performance. Leadership role to the district by motivating, coaching, and influencing reps to revenue goal achievement. Integrated territory mapping goals during company merger transition and upsizing/downsizing.

Ranked 1st of 7 Districts in Capital Revenue in 4/5 qtrs. Q1’09 through Q1’10

122% to plan in MammoSite District sales Q2’09 – 2nd of 7 Districts

$415,452 revenue growth in District Eviva Biopsy Sales FY’09; 2nd of 7 Districts

19% increase in District Celero Biopsy Sales FY’08

Developed 2 Circle of Excellence Award winners; promoted 2 team members to Senior Specialist Role

Breast Surgical Sales Specialist/Trainer – September 2005 to March 2007

Managed multiple call point consultative sale with strategic and tactical plans to Breast Surgeons and Radiation Oncologists selling the MammoSite Brachytherapy implantable balloon for early-stage breast cancer treatment.

FY’06 - $172,445 growth and 43% increase over ‘05

Eight new Breast Surgeon office accounts – 2nd of 7 specialists

Karl Storz Endoscopy America June 2004 to August 2005

Lower Endoscopy Territory Manager

Increase market share for Urology, Ob/Gyn, and General Surgery scope and instrumentation sets. Drive video and OR integration system conversions for above specialties. Comprehensive surgeon and sterile processing call points.

FY’05 – YTD – 133% to plan-video, 102% to plan – urology, 103% to plan – gyne, 112% to overall plan

FY’04 – 68% increase in Laparoscopic instruments

Sanarus Medical, Inc. September 2002 to May 2004

Territory Business Manager

VC-backed company driving Visica Cryoablation adoption for breast tumor treatment targeting breast surgeons for office-based procedure. Increased market share for Centrica Biopsy System to Radiologists and Breast Surgeons.

FY ’04 – 1st Qrt. – 108% to plan on Visica procedures.

FY ’03 – First TBM to have ten breast surgeons committed and treating patients with Visica.

Conmed Corp. July 1995 to August 2002

Surgical Systems Territory Manager/Trainer

Increased market share for E/S generators and disposables, Smoke Evac devices, Argon Beam Coag Systems, and Lap products. Extensive surgeon and gastroenterologist detailing, in-servicing, and follow-up.Coordinated and taught accredited CEU programs for OR nurses and techs:

FY ’01 - 1st VICE PRESIDENT – PRESIDENT’S CLUB – 139% to quota

FY ’00 - 191% to quota Ultraclean products #3 of 55; 312% to quota Laparoscopic products #2 of 55

FY ’99 - PRESIDENTS CLUB – 104% to overall quota

FY ’98 - 2nd VICE PRESIDENT – PRESIDENT’S CLUB – 117% to quota

FY ’97 - 109% to quota Electrosurgical generators

FY ’96 - PRESIDENT’S CLUB – 104% to overall quota

EDUCATION: BBA Marketing, The University of Iowa

COURSES: Brennan Institute, Accordance Negotiation Skills, Leading for Impact, Leadership Essentials

Contact this candidate